PlainPharmaWatch

CMS Open Payments · Program Year 2024

Washington

Washington received $59,137,876.09 in pharmaceutical-industry payments to 11,796 physicians and 24 teaching hospitals across 151,363 transactions.

$59.1M
Total payments
$38.9M
To physicians
$17.1M
To teaching hospitals
#18
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $59.1M in payments to 11,796 physicians and 24 teaching hospitals in Washington. That ranks Washington #18 of 59 states and territories (0.4% of the US total), averaging $3.3K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Washington pairs above-median payment volume with a physician-heavy payment mix.

#18
of 59 states
0.4%
of the national total
65.8%
to physicians vs. hospitals
11,796
physicians paid

What the Data Shows for Washington

Washington's Open Payments file is hospital-weighted: 28.9% of $59.1M went to 24 teaching hospitals ($712.9K each), with 65.8% on 11,796 physicians.

On the national dollar ranking it is still #18 of 59 (0.4% of US payments). Average transaction $390.70. Leading nature of payment: "Royalty or License" at $16.8M (28.5% of the state file; top-three natures 71.1%).

Washington sits in the 71st percentile (mid-pack). Just above: Colorado ($63.4M). Just below: Maryland ($54.7M). For context: top-ranked California ($342.4M) is 5.8× larger than Washington. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Washington are distributed between physicians and teaching hospitals.

Physician Payments

$38.9M

65.8% of total · 11,796 recipients · $3.3K avg

Teaching Hospital Payments

$17.1M

28.9% of total · 24 hospitals · $712.9K avg

Payment Breakdown by Type

Washington has 16 types of pharmaceutical payments. "Royalty or License" accounts for 28.5%.

Nature concentration in Washington

Top three Open Payments natures are 71.1% of state dollars; residual is every other reported nature

Royalty or License$16.8MConsulting Fee$13.4MCompensation for Services Ot…$11.8MAll other natures (13)$17.1M

Payment categories in Washington

Top categories by total reported dollar volume

1. Royalty or License$16.8M2. Consulting Fee$13.4M3. Compensation for Services…$11.8M4. Grant$4.6M5. Food and Beverage$4.5M6. Travel and Lodging$4.0M7. Education$1.6M8. Honoraria$685.7K9. Long-Term Medical Supply …$515.4K10. Compensation for Faculty…$511.3K
Payment Type Amount Transactions
Royalty or License $16.8M 419
Consulting Fee $13.4M 3,472
Compensation for Services Other Than Consulting $11.8M 4,678
Grant $4.6M 178
Food and Beverage $4.5M 125,469
Travel and Lodging $4.0M 12,067
Education $1.6M 3,029
Honoraria $685.7K 240
Long-Term Medical Supply or Device Loan $515.4K 364
Compensation for Faculty or Speaker (Medical Education) $511.3K 294
Space Rental or Facility Fees $295.3K 94
Debt Forgiveness $181.9K 124
Gift $107.2K 818
Acquisitions $96.2K 7
Charitable Contribution $27.0K 6
Entertainment $19.3K 104

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Washington totals can and cannot tell you

The aggregate payment figure for Washington measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Washington's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.